Search

Bernard Lipman

Examiner (ID: 17069)

Most Active Art Unit
1505
Art Unit(s)
1754, 1762, 1505, 1796, 1713, 3307
Total Applications
3506
Issued Applications
2903
Pending Applications
208
Abandoned Applications
395

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18326359 [patent_doc_number] => 20230124487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-20 [patent_title] => A CONTROLLED DRUG RELEASE SYSTEM OF PHOTORESPONSIVE NANOCARRIERS, METHODS OF MAKING AND USING THEREOF [patent_app_type] => utility [patent_app_number] => 17/904833 [patent_app_country] => US [patent_app_date] => 2021-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5268 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17904833 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/904833
Controlled drug release system of photoresponsive nanocarriers, methods of making and using thereof Mar 16, 2021 Issued
Array ( [id] => 16990092 [patent_doc_number] => 20210228512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => THERAPEUTIC COMPOUNDS, FORMULATIONS, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/203639 [patent_app_country] => US [patent_app_date] => 2021-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21345 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17203639 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/203639
Therapeutic compounds, formulations, and uses thereof Mar 15, 2021 Issued
Array ( [id] => 18365711 [patent_doc_number] => 20230147302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => PARTICLE SIZE CONTROL [patent_app_type] => utility [patent_app_number] => 17/910868 [patent_app_country] => US [patent_app_date] => 2021-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8772 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17910868 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/910868
PARTICLE SIZE CONTROL Mar 11, 2021 Abandoned
Array ( [id] => 17850546 [patent_doc_number] => 20220280587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => MEDICAL GELS CONTAINING A QUATERNARY AMMONIUM COMPOUND, PHENOXYETHANOL, ALOE VERA JUICE, AND NATURAL SPORICIDAL MOISTURIZERS [patent_app_type] => utility [patent_app_number] => 17/190628 [patent_app_country] => US [patent_app_date] => 2021-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2795 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17190628 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/190628
MEDICAL GELS CONTAINING A QUATERNARY AMMONIUM COMPOUND, PHENOXYETHANOL, ALOE VERA JUICE, AND NATURAL SPORICIDAL MOISTURIZERS Mar 2, 2021 Abandoned
Array ( [id] => 17080570 [patent_doc_number] => 20210275576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR PREVENTION AND/OR IMPROVEMENT OF GENETIC DISORDER [patent_app_type] => utility [patent_app_number] => 17/189973 [patent_app_country] => US [patent_app_date] => 2021-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3729 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17189973 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/189973
MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR PREVENTION AND/OR IMPROVEMENT OF GENETIC DISORDER Mar 1, 2021 Abandoned
Array ( [id] => 16898929 [patent_doc_number] => 20210177845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => PDE9 INHIBITORS FOR TREATING SICKLE CELL DISEASE [patent_app_type] => utility [patent_app_number] => 17/186442 [patent_app_country] => US [patent_app_date] => 2021-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17652 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -42 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17186442 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/186442
PDE9 inhibitors for treating sickle cell disease Feb 25, 2021 Issued
Array ( [id] => 17050554 [patent_doc_number] => 20210259988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => ELECTROSPUN STRUCTURES HAVING A PHARMACEUTICAL AND METHODS OF MAKING AND USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/181671 [patent_app_country] => US [patent_app_date] => 2021-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10194 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17181671 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/181671
ELECTROSPUN STRUCTURES HAVING A PHARMACEUTICAL AND METHODS OF MAKING AND USING THE SAME Feb 21, 2021 Abandoned
Array ( [id] => 16913776 [patent_doc_number] => 20210186868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => IMPLANTABLE DEPOTS FOR THE CONTROLLED RELEASE OF THERAPEUTIC AGENTS [patent_app_type] => utility [patent_app_number] => 17/248949 [patent_app_country] => US [patent_app_date] => 2021-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44933 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17248949 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/248949
Implantable depots for the controlled release of therapeutic agents Feb 14, 2021 Issued
Array ( [id] => 17034954 [patent_doc_number] => 20210251912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => Composition and Method for Transdermal Delivery of Cannabidiol (CBD) and 9-Tetrahydrocannabinol (THC) [patent_app_type] => utility [patent_app_number] => 17/170231 [patent_app_country] => US [patent_app_date] => 2021-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7956 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17170231 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/170231
Composition and method for transdermal delivery of cannabidiol (CBD) and D Feb 7, 2021 Issued
Array ( [id] => 17005536 [patent_doc_number] => 20210236697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => INJECTABLE COMPOSITE INKS AND METHODS FOR MAKING AND USING THEREOF [patent_app_type] => utility [patent_app_number] => 17/150038 [patent_app_country] => US [patent_app_date] => 2021-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14820 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150038 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/150038
Injectable composite inks and methods for making and using thereof Jan 14, 2021 Issued
Array ( [id] => 18194850 [patent_doc_number] => 20230048369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-16 [patent_title] => POLYOXAZOLINE MODIFICATIONS MITIGATE STRUCTURAL DEGENERATION OF BIOPROSTHETIC HEART VALVES [patent_app_type] => utility [patent_app_number] => 17/792694 [patent_app_country] => US [patent_app_date] => 2021-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7238 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792694 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/792694
POLYOXAZOLINE MODIFICATIONS MITIGATE STRUCTURAL DEGENERATION OF BIOPROSTHETIC HEART VALVES Jan 12, 2021 Pending
Array ( [id] => 20527224 [patent_doc_number] => 12545648 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-10 [patent_title] => Benzopyrazole compound [patent_app_type] => utility [patent_app_number] => 17/789662 [patent_app_country] => US [patent_app_date] => 2020-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20098 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789662 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/789662
Benzopyrazole compound Dec 29, 2020 Issued
Array ( [id] => 17685687 [patent_doc_number] => 20220192979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => Liquid Micro-Dosing Product Containing an Effective Amount of Cannabis and Process for Making the Same [patent_app_type] => utility [patent_app_number] => 17/129519 [patent_app_country] => US [patent_app_date] => 2020-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9057 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17129519 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/129519
Liquid Micro-Dosing Product Containing an Effective Amount of Cannabis and Process for Making the Same Dec 20, 2020 Abandoned
Array ( [id] => 18167354 [patent_doc_number] => 20230033961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-02 [patent_title] => COSMETIC COMPOSITION HAVING GLOSS AND LASTING PROPERTIES [patent_app_type] => utility [patent_app_number] => 17/787206 [patent_app_country] => US [patent_app_date] => 2020-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7650 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17787206 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/787206
COSMETIC COMPOSITION HAVING GLOSS AND LASTING PROPERTIES Dec 17, 2020 Pending
Array ( [id] => 18225733 [patent_doc_number] => 20230064727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => COMPOSITION FOR SKIN EXTERNAL APPLICATION [patent_app_type] => utility [patent_app_number] => 17/789363 [patent_app_country] => US [patent_app_date] => 2020-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13319 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789363 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/789363
COMPOSITION FOR SKIN EXTERNAL APPLICATION Dec 16, 2020 Pending
Array ( [id] => 20370653 [patent_doc_number] => 12478063 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-25 [patent_title] => Nanosystems based on nanocomposites and natural extracts [patent_app_type] => utility [patent_app_number] => 18/257539 [patent_app_country] => US [patent_app_date] => 2020-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 16 [patent_no_of_words] => 15325 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18257539 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/257539
Nanosystems based on nanocomposites and natural extracts Dec 13, 2020 Issued
Array ( [id] => 18141151 [patent_doc_number] => 20230014993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-19 [patent_title] => MINERAL SUPPLEMENTS FOR RUMINANT NUTRITION [patent_app_type] => utility [patent_app_number] => 17/784575 [patent_app_country] => US [patent_app_date] => 2020-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5361 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17784575 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/784575
Mineral supplements for ruminant nutrition Dec 10, 2020 Issued
Array ( [id] => 20491521 [patent_doc_number] => 12533376 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-27 [patent_title] => Prophylactic or therapeutic agent for disease induced by oxidative stress [patent_app_type] => utility [patent_app_number] => 17/113886 [patent_app_country] => US [patent_app_date] => 2020-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 52 [patent_no_of_words] => 19360 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 200 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17113886 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/113886
Prophylactic or therapeutic agent for disease induced by oxidative stress Dec 6, 2020 Issued
Array ( [id] => 17625861 [patent_doc_number] => 20220160876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => MACROMOLECULAR SYSTEM FOR DELIVERY OF EXOGENOUS ACTIVE SUBSTANCES WITH IMMUNE TRAP TO AVOID NEUTRALIZATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/104170 [patent_app_country] => US [patent_app_date] => 2020-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3298 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104170 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/104170
MACROMOLECULAR SYSTEM FOR DELIVERY OF EXOGENOUS ACTIVE SUBSTANCES WITH IMMUNE TRAP TO AVOID NEUTRALIZATION THEREOF Nov 24, 2020 Abandoned
Array ( [id] => 16709967 [patent_doc_number] => 20210077114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => IMPLANTABLE DRUG ELUTING SYSTEM AND METHOD OF USE [patent_app_type] => utility [patent_app_number] => 17/102125 [patent_app_country] => US [patent_app_date] => 2020-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8481 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102125 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/102125
IMPLANTABLE DRUG ELUTING SYSTEM AND METHOD OF USE Nov 22, 2020 Abandoned
Menu